Introduction
Genotoxicity testing is an important part of the regulatory hazard assessment of chemicals. It is undertaken for (i) detecting chemicals that might cause genetic damage in germ cells and thus increase the burden of heritable (genetic) disease in the human population and (ii) detecting chemicals that might be carcinogenic (based on the assumption that mutagenesis, for example in somatic cells, is a key event in the process of carcinogenesis). Since no method alone is able to detect all possible genotoxic events, a wide array of test systems has been developed and accepted internationally in regulatory schemes.
These regulatory schemes and strategies vary to a large extent, depending on the types of chemicals and intended use (e.g. whether the chemicals are industrial chemicals, pharmaceutical drugs, food additives or constituents), they also vary-for the same types of chemicals-from a regulatory authority to another. However, a dominant trend can be recognized. Most often, a two-tiered integrated testing approach is used. Tier 1 includes in vitro assays. Tier 2 involves the use of short-term in vivo studies (usually a bone marrow cytogenetics assay) to assess whether any potential for mutagenicity detected at the Tier 1 in vitro stage is actually expressed in the whole animal. Thus, negative results in vitro are usually considered sufficient to indicate lack of mutagenicity, whereas a positive result is not considered sufficient to indicate that the chemical represents a mutagenic hazard (i.e. it could be a false positive). The above approach to mutagenicity testing has been adopted throughout the European Union (EU) and has been recommended internationally as part of the strategy for predicting and quantifying mutagenic and carcinogenic hazard (1-4) (see also the Technical Guidance Documents of the European Chemicals Agency: http:// guidance.echa.europa.eu/docs/guidance_document/information_ requirements_r7a_en.pdf?vers520_08_08).
According to an assessment carried out by the former European Chemicals Bureau (ECB), the in vivo genotoxicity studies, shortly followed by carcinogenicity bioassay, are posing high demand for test-related recourses (5, 6) . Among those, the micronucleus test in rodents is the most widely used as a follow-up to positive in vitro mutagenicity results: therefore, the development and extensive use of estimation techniques based on the concept of Structure-Activity Relationships-such as (Quantitative) Structure-Activity Relationships [(Q)SAR], read-across and grouping of chemicalsmight have a huge saving potential for this end point (7) .
A recent survey of the (Q)SAR models for mutagenicity and carcinogenicity [performed jointly by the Istituto Superiore di Sanita' (ISS) and ECB] has indicated that no (Q)SAR models for in vivo micronucleus are available in the public domain (8) . The present study is aimed at filling this gap of information by identifying Structural Alerts (SAs) for in vivo micronucleus in rodents.
The SAs for a toxicological end point are molecular functional groups or substructures thought to be linked to that type of toxicity. Following the seminal research by Miller and Miller (9) on the mechanisms of chemical carcinogenicity and the subsequent development of the bacterial model of (genotoxic) carcinogenicity by Ames (10), Ashby (11) compiled a well-known list of SAs for carcinogenicity . Given that most of the carcinogens known at that time were genotoxic, Ashby's SAs apply to Salmonella mutagenicity as well. The main role of the SAs is that of preliminary or largescale screening. The SAs are excellent tools for coarse-grain characterization of chemicals, including description of sets of chemicals, preliminary hazard characterization, category formation and priority setting (enrichment). Knowledge on action mechanisms, as exemplified by the SAs, is routinely used in SAR assessment in a regulatory context [see, e.g. the mechanistically based reasoning as presented in (12) ] and is at the basis of popular commercial (e.g. DEREK; Lhasa Ltd) and non-commercial software systems (e.g. Oncologic, US Environmental Protection Agency, http://www.epa.gov/oppt/ newchems/tools/oncologic.htm).
In the framework of a collaboration between ISS and ECB, recently a rule base for mutagens and carcinogens has been designed and implemented in the software Toxtree (present version 1.60). It uses a structure-based approach consisting of a refined compilation of SAs for carcinogenicity and Salmonella mutagenicity. It also offers three mechanistically based QSARs for congeneric classes (aromatic amines and aldehydes) (13, 14) . Toxtree 1.60 is freely available from the website: http://ecb.jrc.ec.europa.eu/qsar/qsar-tools/index.php? c5TOXTREE.
The present paper is aimed at the identification of SAs for the in vivo micronucleus assay in rodents. This compilation is based on both existing hypotheses on the mechanisms of toxic action (by e.g. checking the relative influence on micronucleus induction of DNA reactivity and protein binding) and on a structural analysis of the chemicals tested in the assay. Analyses and considerations relative to the role of the in vivo micronucleus assay in the pre-screening of chemical carcinogenicity are presented as well.
Data and methods

Data
Rodent in vivo micronucleus data that are easily accessible to the public are quite limited. For example, the query: 'in vivo micronucleus' generates only 240 chemicals in the Chemical Carcinogenesis Research Information System (CCRIS) (http:// toxnet.nlm.nih.gov/cgi-bin/sis/search) (accessed January 2009). Thus, for the structural analysis of compounds tested in the in vivo micronucleus, the considerably larger commercial database 'FDA SAR Genetox Database'; Leadscope Inc. (http:// www.leadscope.com/product_info.php?products_id577) was used.
Out of the several genetic toxicity end points included in the above database, only the in vivo micronucleus data were considered in this analysis. This database has compiled micronucleus data for .700 chemicals and includes data from several sources, e.g. CCRIS (http://toxnet.nlm.nih.gov/cgi-bin/ sis/htmlgen?CCRIS), US National Toxicology Program (NTP), US Food and Drug Administration (FDA) and peer-reviewed publications. After excluding substances without unique structure or with inconclusive results, 690 chemicals remained; of them, 178 are micronucleus positive and 512 are micronucleus negative.
A large majority of the data are based on the analysis of micronuclei in bone marrow cells [for rationale of and details on the assay, see (15) (16) (17) (18) ].
A description and preliminary analysis of the FDA SAR Genetox Database is contained in (19) . However, the data actually considered in the above paper refer to a larger database integrated with results from industry, not available to the public. Thus, the results in this paper cannot be compared directly with those of (19) .
Data on the rodent carcinogenicity bioassay and Salmonella mutagenicity of chemicals were retrieved from the ISSCAN v3a database (20) . ISSCAN is a curated database characterized by the critical selection of the biological calls and is freely available at:
http://www.iss.it/ampp/dati/cont.php?id5233&lang51 &tipo57. Of 1153 chemicals with carcinogenicity studies, 718 have positive calls, whereas 365 have negative calls and 70 equivocal calls. For a subset of chemicals (n 5 835), ISSCAN v3a also contains Salmonella mutagenicity data.
The overlapping between ISSCAN v3a and the database on micronucleus results used here is 183 chemicals for rodent carcinogenicity and 185 chemicals for Salmonella mutagenicity.
Data relative to the in vitro Chromosomal Aberrations assay were retrieved from the Kirkland-Lhasa compilation (21) .
Chemical descriptors
A number of whole-molecule properties of the chemicals were calculated. These were as follows: hydrophobicity, parameterized through the octanol-water partition coefficient (logP); size/polarizability, parameterized through molar refractivity (MR) and ability to form weak bonds with proteins/receptors, parameterized through Andrews' DG.
MR (C-MR) and logP (C-logP) were calculated with the software Bio-loom by Bio-byte (http://www.biobyte.com/ index.html). Andrews' DG was calculated manually according to Andrews et al. (22) .
The number of structures with all parameters calculated was 668 (Table I) .
Results and discussion
The micronucleus assay into context: relationships with other toxicological end points Since the main role of the in vivo micronucleus assay in regulatory schemes is that of confirming (or disproving) the positive in vitro results in the context of the pre-screening of carcinogenicity, it is of interest to check how the in vivo micronucleus results relate to the rodent carcinogenicity data and to the in vitro test that has a primary role in its prediction, i.e. the Salmonella typhimurium (Ames) test.
Tables II and III display the relationships between the in vivo micronucleus and the two reference tests. The results for the micronucleus assay were retrieved from the 'FDA SAR Genetox Database', and results for rodent carcinogenicity and the Ames test were retrieved from the ISSCAN v3a database (details of the databases are in the Data and methods). Table II shows that the in vivo micronucleus assay is poorly sensitive to the rodent carcinogens: $60% of the rodent carcinogens are not detected by the micronucleus assay. At the same time, poor sensitivity of the micronucleus assay to potential in vitro mutagens is also apparent from Table III . It should be emphasized that the present results obtained with the large Leadscope micronucleus database are in agreement with previous analyses based on smaller data sets available in the public domain (23). Since in several regulatory schemes the micronucleus assay is used as a follow-up to further assess the in vitro positives, it is of interest to check the ability of the micronucleus assay to discriminate between carcinogens and non-carcinogens in the subset of Salmonella positives. Table IV shows that of 66 genotoxic carcinogens, the in vivo micronucleus assay fails to identify .50% (n 5 34). It should be emphasized that the lack of positivity in micronucleus of the above carcinogens cannot be referred only or mainly to the difference of genetic end point with Salmonella; in fact, a quick check of the literature indicated that at least 26 of the 34 carcinogens negative in micronucleus are reported to be also in vitro clastogens (data not shown). This is in agreement with the evidence that the large majority of Salmonella mutagens are able to induce chromosomal damage as well (24) (25) (26) .
The above result is confirmed by Table V that displays the relationship between carcinogenicity and micronucleus in the subset of chemicals positive in the in vitro Chromosomal Aberrations test. Of 80 chemicals inducing chromosomal aberrations, a very high proportion (71) is carcinogenic. It appears that the micronucleus assay is positive for only $50% of the carcinogens and is negative for $50% of the noncarcinogens, with an overall discriminatory result close to a random one.
As a matter of fact, the issue of the low sensitivity of the micronucleus assay to rodent carcinogens has been already recognized; additionally, more sensitive approaches to in vivo prescreening of carcinogenicity are currently under evaluation (3).
The search for the Structure Alerts: preliminary analyses A plethora of mechanisms for micronucleus induction has been reported. Micronuclei are markers of both clastogenic (chromosome breakage) and aneugenic (change in the chromosomes number, usually by loss) effects. It is generally assumed that such effects are generated through a range of different pathways. Evidence (mainly gathered from in vitro studies) indicates that micronuclei can be induced by, e.g. typical DNAreactive agents (e.g. alkylating agents like methylmethane sulfonate), mitotic spindle poisons (e.g. colcemide, vincristine), topoisomerase II inhibitors (e.g. etoposide). The latter effects are likely related to interference with proteins. Other micronuclei inducers are thought to be clastogenic through aspecific disturbance of cytokinesis due to the level of their lipophilicity (16, 27, 28) .
In view of this variety of mechanisms, some preliminary analyses were performed. In one analysis, the relative influence on micronucleus generation of interference with DNA and protein binding was checked by recording the distribution of SAs for the two effects in the in vivo micronucleus database. As probes for interference with DNA and mutagenicity, we used the SAs for carcinogenicity-mutagenicity implemented in Toxtree 1.60. The large majority of these alerts are associated with genotoxic carcinogenicity, more precisely with DNAreactive mechanisms of action (13) . As probes for protein binding, we used the alerts implemented in the QSAR Toolbox software of the Organization for Economic Co-operation and Development (http://www.oecd.org/document/23/0,3343,en_ 2649_34379_33957015_1_1_1_1,00.html). The latter alerts were mainly developed from mechanistic knowledge of skin sensitization and model the covalent (strong) binding to proteins.
The results of the above analysis are displayed in Figure 1 . A receiver operating characteristics (ROC) graph is used to visualize the agreement between two dichotomic properties Structural
on the y-axis and false-positive rate (1 minus specificity) on the x-axis. In an ROC graph, perfect agreement is located at the left upper corner; the diagonal line represents random results (29, 30) . Figure 1 shows that the SAs for carcinogenicity-mutagenicity correlate to some extent with the induction of micronuclei, whereas the SAs for covalent protein binding do not correlate at all (in the graph, they are on the diagonal line coding for random results).
The ability of a molecule to interact with biological material depends on the reactive groups/substructures present in the molecule (as exemplified by the SAs); however, it can be modulated by the nature of the remaining part of the molecule in which an SA is embedded. A general effect of primary importance is that of bioavailability. Thus, in a further analysis, we considered two chemical descriptors well known as to be linked to bioavailability: logP (hydrophobicity) and MR (31) . The two descriptors were calculated with the C-QSAR software (Daylight, Inc., http://www.daylight.com/about/ index.html) for all the chemicals in the micronucleus database. In addition, we considered a parameter (Andrews' DG) related to the ability of establishing weak bonds with receptors and in general with proteins (22) . Table I reports the mean and the range of values for positive and negative micronucleus results. Even though the distribution of the three parameters shows some differences in the two subsets of chemicals, a statistical analysis indicates that such differences explain only an extremely limited portion of the different responses to the micronucleus test (only up to 2% of the variance; analytical results not shown). While not excluding differential influence within the individual chemical classes, these results indicate that there is not a uniform effect of the above physical chemical forces on all the chemicals.
Identification of SAs for in vivo micronucleus
Overall, the above preliminary analyses pointed to genotoxic effects (as exemplified by the SAs for carcinogenicitymutagenicity) as an important determinant of micronuclei induction. This is in agreement with previous evidence on the ability of various DNA-damaging agents to induce micronuclei as well (16) . Thus, we developed the list of SAs for in vivo micronucleus using the carcinogenicity-mutagenicity alerts in Toxtree as a core and then searched with data mining approaches for additional substructures specific to the micronucleus-positive chemicals. From the Toxtree alerts for carcinogenicity-mutagenicity, we excluded alerts specific for non-genotoxic mechanisms of carcinogenicity [i.e. thiocarbonyls; poly-halogenated cycloalkanes; halogenated benzenes, polycyclic aromatic hydrocarbons and dibenzodioxins (13)].
Using linear discriminant analysis as the analytical tool and ROC plots as the graphical tool, a series of additional substructures were added/removed to/from the Toxtree alerts in order to increase sensitivity and specificity. In these analyses, we screened the very large (.27 000) collection of substructural patterns and functional groups contained in the software Leadscope Enterprise 2.4.15-6 (http://www.leadscope. com/product_info.php?products_id581). We also rechecked the Toolbox protein-binding alerts for individual substructures related to micronucleus induction. In the above process, we used a combination of manual and statistical procedures. Correlations between the SAs in Toxtree and the new candidate substructures were checked statistically, and their structural overlapping was inspected by eye. A reduced number of promising candidates were added to the Toxtree SAs; their contribution to improve the separation between micronucleus negatives and micronucleus positives was assessed with Linear Discriminant Analysis, as implemented in the SAS/STAT statistical software (http:// www.sas.com/technologies/analytics/statistics/stat/index.html). In SAS/STAT, the default significance level to add a new variable is set at P 0.15.
The result is the optimized list of alerts in Supplementary Appendix 1. Together with the Toxtree alerts, it contains five additional substructures identified in the course of this research. For the sake of clarity, the codes of the alerts in Toxtree are maintained, whereas the five additional alerts have new codes (SA_32 to SA_36).
Even if new SAs were derived through statistical procedures (see above), it is possible to generate hypotheses about the underlying mechanisms of action.
The 1,3-dialkoxy-benzene substructure (SA32) is a structural motif occurring in several substances known to act as spindle poisons or topoisomerase II inhibitors (32) . It has been shown that the alkoxy-benzene moiety is an important feature in binding interaction with tubuline (33) and for inhibition of topoisomerase II (34) .
The phenoxy-benzene substructure (SA33) is common to several pyrethroids insecticides, for which micronuclei induction has been documented (35) (36) (37) (38) (39) (40) (41) . Nonetheless, mechanism of genotoxicity of these compounds is still unclear so that a direct relationship with the structural feature cannot be derived.
SA34 represents a molecular framework that could account for non-covalent interactions with proteins or DNA. Such interactions, as in the case of DNA intercalation or groove binding (42) , are potentially genotoxic.
Oxolane (SA35) is a chemical feature present in an important class of antimetabolites, the nucleoside analogues drugs. Induction of micronuclei by these substances (43, 44) arise presumably from the ability of the nucleoside analogues to inhibit DNA polymerase function and/or to be incorporated into DNA as fraudulent nucleoside. It has to be pointed out that SA35 may suffer of low specificity due to its derivation strictly database dependent. In fact, the tetrahydrofuran moiety represents the chemical skeleton of biologically important aldopentoses, such as ribose, that may be erroneously identified as positive alerting substances.
Chemicals containing a carbodiimide substructure (SA36) were found in some cases to increase micronucleus frequencies (45) . Though mechanism of action is not clear, covalent modification of key macromolecules (DNA and/or proteins) cannot be ruled out. Figure 2 displays the agreement between the presence of the alerts for in vivo micronucleus and the experimental results for this end point. Of 512 negatives, the specificity of the SAs is 0.54. The sensitivity is 0.66 of 178 positives. The overall accuracy is 0.57. The positive predictivity (i.e. probability for a chemical with SA to be positive) is 0.33. For a comparison, the ROC graph shows the newly developed alerts for micronucleus together with those for carcinogenicity-mutagenicity and protein binding. It appears that the performance of the final list of alerts for in vivo micronucleus is considerably higher.
Operational characteristics of the SAs
Another insight is provided by Tables VI and VII. Table VI gives the positive predictivity for the individual alerts for in vivo micronucleus (i.e. rate of micronucleus positives among the target chemicals of the SAs) in the FDA SAR Genetox Database. A striking feature is the relatively low percentage of positives identified by many SAs; in other words, often the toxic potential of the substructures (i.e. the SAs) is not translated into actual toxicity in the experimental system. This result is confirmed by Table VII. For a number of SAs common to both micronucleus and carcinogenicity, Table VII compares the respective Positive Predictivities. It appears that the average positive predictivity for micronucleus is 33%, whereas that for carcinogenicity is 80% and that for Salmonella mutagenicity is 70%.
Thus, Table VII points to a limited sensitivity of the in vivo micronucleus assay in respect to its potential target chemicals, and agrees with the evidence in Tables II, III , IV and V. Since the bone marrow (main target of the test) is an organ easily accessible to the blood stream, it can be hypothesized that the lack of effects shown by several SA-containing chemicals is due to the interference of many other possible targets for reaction encountered in the in vivo situation; this diminishes the probability for the chemicals of reaching and interacting with the molecular target(s) of the micronucleus test. For example, highly reactive chemicals are likely to react with any target encountered in the organism (e.g. proteins, water, etc.) before reaching the bone marrow. For other chemicals, the generation of labile metabolites may be the cause of lack of effect in the micronucleus. Together with this, the bioavailability of the compounds and their metabolites can also play a role in the overall result of the test. As outlined above in this work, we investigated if a general effect of bioavailability on the sensitivity of micronucleus was apparent. To this aim, we considered two chemical descriptors well known as to be linked to bioavailability: logP (hydrophobicity) and MR (bulkiness/polarizability) (31). However, no general effect of logP and MR was found (Table I) . Overall, these elements suggest that there is not one unifying explanation for the lack of effect shown in the micronucleus test by several rodent carcinogens (which also induce chromosomal damage), but explanations should be sought on a class-by-class basis.
Conclusions
The SAs identified in this study provide a coarse-grain filter for a preliminary screening of potentially in vivo mutagens, aimed at enriching the target of the evaluations. Real life experiences in the design of experiments for large numbers of chemicals have demonstrated the efficiency of the structural considerations in fine-tuning the prioritization process [see e.g. the successful prioritization of candidates for rodent bioassay performed by the NTP (46)]. In the present case, the enrichment of the target is demonstrated by the fact that the percentage of micronucleus positives among the chemicals with SAs (33%) (Table VII) is considerably higher than the 25% of chemicals positive in the whole FDA SAR Genetox database (178 of 690 chemicals). In a risk assessment process, further information (e.g. QSARs for individual classes, welldesigned experiments, etc.) will follow this initial screening step. In an industrial setting, the early recognition of SAs may suggest either to stop the development of or to substantially modify a line of products, thus saving considerable resources. It should be added that the positive predictivity of the SAs for micronucleus are quite inferior to that for carcinogenicity or Salmonella mutagenicity (Table VII) . In our opinion, this has to be put in connection with the general low sensitivity of the micronucleus test; often chemical functionalities and substructures (i.e. SAs) that are generally active in other experimental settings (e.g. rodent bioassay, in vitro clastogenicity, Salmonella mutagenicity) do not exert their potential reactivity in this experimental system.
Overall, two lines of future research seem to be necessary. One regards the role of this assay in testing strategies and its possible improvements; as a matter of fact, its recognized limited sensitivity has stimulated various attempts to, e.g. extend the micronucleus protocol to include other target organs, such as hepatocytes, or further develop additional in vivo systems like the Comet assay (3). In the future, the results from such attempts should be incorporated into revised testing guidelines.
Another line of research regards the improvement of the predictivity of the SAs for the micronucleus assay, in its present state. One avenue is modelling individually the chemical classes with QSAR methods (31, 47) . For example, analyses performed in this study have shown that logP cut-offs can be identified for the classes of nitroaromatics (negatives for logP . 0.0), aromatic diazo (negatives for logP , 3.7) and oxolanes (negatives for logP . 1.5). The consideration of these cut-offs increases the specificity of these SAs from 0.54 to 0.60 (analytical results not shown). It can be hypothesized that the consideration of parameters linked to chemical reactivity, such as the energy of the Highest Occupied Molecular Orbital, or that of the Lowest Unoccupied Molecular Orbital may contribute to better modulate the applicability of the individual SAs. Another research line that we plan in our laboratory is to study and model the metabolic fate of chemicals, so to be able to better define the SAs.
The present SAs for the in vivo micronucleus assay have been implemented as independent rule base of the expert system Toxtree 1.60, which is a software open-source and freely available at the website: http://ecb.jrc.ec.europa.eu/qsar/ qsar-tools/index.php?c5TOXTREE.
Supplementary data
Supplementary Appendix 1 is available at Mutagenesis Online. 
